Evidence map›Paper›PMID 25601796›Full record

ArticleJournal of molecular recognition : JMR2015

Dynamics of CYP51: implications for function and inhibitor design.

Xiaofeng Yu, Vlad Cojocaru, Ghulam Mustafa, Outi M H Salo-Ahen, Galina I Lepesheva, Rebecca C Wade

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of molecular recognition : JMR, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Challenges in Chagas Disease Drug Development.Molecules (Basel, Switzerland) · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Catalytic diversity and homotropic allostery of two Cytochrome P450 monooxygenase like proteins from Trichoderma brevicompactum.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2017
    Article
  12. Article
  13. Article
  14. The Role of Protein-Protein and Protein-Membrane Interactions on P450 Function.Drug metabolism and disposition: the biological fate of chemicals · 2016
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Xiaofeng YuMolecular and Cellular Modeling Group, Heidelberg Institute for Theoretical Studies, Heidelberg, Germany.
Vlad Cojocaru
Ghulam Mustafa
Outi M H Salo-Ahen
Galina I Lepesheva
Rebecca C Wade
Heidelberg Institute for Theoretical Studies · DEÅbo Akademi University · FIHeidelberg University · DEMax Planck Institute for Molecular Biomedicine · DEVanderbilt University · US

Funding

Structural Requirements for Sterol 14alpha-DemethylasesR01GM067871 · NIGMS · VANDERBILT UNIVERSITY · PI LEPESHEVA, GALINA I · 2004 to 2023
$7.2M
NIGMS NIH HHS GM067871NIGMS NIH HHS R01 GM067871
6 · The paper itself

Abstract

Sterol 14α-demethylase (cytochrome P450 family 51 (CYP51)) is an essential enzyme occurring in all biological kingdoms. In eukaryotes, it is located in the membrane of the endoplasmic reticulum. Selective inhibitors of trypanosomal CYP51s that do not affect the human CYP51 have been discovered in vitro and found to cure acute and chronic mouse Chagas disease without severe side effects in vivo. Crystal structures indicate that CYP51 may be more rigid than most CYPs, and it has been proposed that this property may facilitate antiparasitic drug design. Therefore, to investigate the dynamics of trypanosomal CYP51, we built a model of membrane-bound Trypanosoma brucei CYP51 and then performed molecular dynamics simulations of T. brucei CYP51 in membrane-bound and soluble forms. We compared the dynamics of T. brucei CYP51 with those of human CYP51, CYP2C9, and CYP2E1. In the simulations, the CYP51s display low mobility in the buried active site although overall mobility is similar in all the CYPs studied. The simulations suggest that in CYP51, pathway 2f serves as the major ligand access tunnel, and both pathways 2f (leading to membrane) and S (leading to solvent) can serve as ligand egress tunnels. Compared with the other CYPs, the residues at the entrance of the ligand access tunnels in CYP51 have higher mobility that may be necessary to facilitate the passage of its large sterol ligands. The water (W) tunnel is accessible to solvent during most of the simulations of CYP51, but its width is affected by the conformations of the heme's two propionate groups. These differ from those observed in the other CYPs studied because of differences in their hydrogen-bonding network. Our simulations give insights into the dynamics of CYP51 that complement the available experimental data and have implications for drug design against CYP51 enzymes.

Indexed as

Catalytic DomainCrystallography, X-RayCytochrome P-450 CYP2C9Drug DesignHumansHydrogen BondingMolecular Dynamics SimulationProtein Structure, SecondaryProtozoan ProteinsSolventsSterol 14-DemethylaseSubstrate SpecificityTrypanosoma brucei bruceiCYP2C9 protein, humanCYP51A1 protein, humanCytochrome P-450 CYP2C9Protozoan ProteinsSolventsSterol 14-DemethylaseCYP51cytochrome P450heme propionate groupsligand tunnelmembrane-bound proteinmolecular dynamics simulationprotein dynamicssterol 14α-demethylase

Identifiers

PMID25601796
PMCPMC4337246
OpenAlexW1518136201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.